Imiquimod Cream 5%
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Imiquimod Cream 5%, covering 2009-03-10 to 2020-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% [Phase 4]